ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
106 hedge funds and large institutions have $344M invested in ChemoCentryx, Inc. in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 18 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $354M → $344M (-$10.1M)
5% less call options, than puts
Call options by funds: $1.92M | Put options by funds: $2.02M
8% less funds holding
Funds holding: 115 → 106 (-9)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
+$3.32M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.73M |
| 3 |
FI
Fosun International
Hong Kong,
China
|
+$1.92M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.84M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$3.14M |
| 2 |
JP Morgan Chase
New York
|
-$2.31M |
| 3 |
Millennium Management
New York
|
-$2.29M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.88M |
| 5 |
Two Sigma Investments
New York
|
-$1.41M |
CCXI Hedge Fund Activity: Q3 2018 in Review
106 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2018, worth a combined $344M — down 2.8% from $354M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CCXI and 9 opened new positions — a net loss of 9 holders — while 33 trimmed existing stakes and 35 added.
The largest buyer was Carmignac Gestion, adding an estimated $3.32M. The largest seller was BVF Inc, cutting an estimated $3.14M.
- 106 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2018, down from 115 in Q2 2018.
- Funds reported $344M of ChemoCentryx, Inc. stock for Q3 2018, down 2.8% quarter-over-quarter.
- 9 funds opened new ChemoCentryx, Inc. positions in Q3 2018 and 18 closed out, a net change of -9 holders.
- The largest ChemoCentryx, Inc. buyer in Q3 2018 was Carmignac Gestion, an estimated $3.32M added.
- The largest ChemoCentryx, Inc. seller in Q3 2018 was BVF Inc, an estimated $3.14M sold.
Based on aggregated 13F filings for Q3 2018.